ClinicalTrials.Veeva

Menu

Effect of Dexmedetomidine on Bispectral Index and Propofol Requirements During Different Menstrual Cycle

Fudan University logo

Fudan University

Status and phase

Completed
Phase 4

Conditions

Abnormal Menstrual Cycle

Treatments

Drug: dexmedetomidine

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The study was done to evaluate the effects of the follicular and luteal phases of the menstrual cycle on sedation level at loss of consciousness and bispectral index reach to 50 during propofol anesthesia, in patients with and without preoperative intravenous dexmedetomidine .

Enrollment

110 patients

Sex

Female

Ages

24 to 40 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • a regular menstrual cycle
  • elective gynecologic surgery

Exclusion criteria

  • pregnancy
  • breastfeeding
  • obesity
  • known hypersensitivity to drugs used in the study protocol;
  • use of psychotropic drugs and steroids within 72 hours before the surgery
  • central nervous system injury
  • renal impairment
  • alcoholism and opioid addiction.

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

Double Blind

110 participants in 1 patient group

menstrual cycle,dexmedetomidine
Other group
Treatment:
Drug: dexmedetomidine

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems